144 related articles for article (PubMed ID: 38644608)
21. H19 Functions as a Competing Endogenous RNA to Regulate EMT by Sponging miR-130a-3p in Glioma.
Hu Q; Yin J; Zeng A; Jin X; Zhang Z; Yan W; You Y
Cell Physiol Biochem; 2018; 50(1):233-245. PubMed ID: 30282068
[TBL] [Abstract][Full Text] [Related]
22. Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells.
Zhang W; Zhou K; Zhang X; Wu C; Deng D; Yao Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649811
[TBL] [Abstract][Full Text] [Related]
23. Curcumin attenuates lncRNA H19‑induced epithelial‑mesenchymal transition in tamoxifen‑resistant breast cancer cells.
Cai J; Sun H; Zheng B; Xie M; Xu C; Zhang G; Huang X; Zhuang J
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179087
[TBL] [Abstract][Full Text] [Related]
24. Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma.
Ye Y; Guo J; Xiao P; Ning J; Zhang R; Liu P; Yu W; Xu L; Zhao Y; Yu J
Cancer Lett; 2020 Jan; 469():310-322. PubMed ID: 31705929
[TBL] [Abstract][Full Text] [Related]
25. Transcription factor HIF1α promotes proliferation, migration, and invasion of cholangiocarcinoma via long noncoding RNA H19/microRNA-612/Bcl-2 axis.
Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
Transl Res; 2020 Oct; 224():26-39. PubMed ID: 32505707
[TBL] [Abstract][Full Text] [Related]
26. The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers.
Ghasemian M; Zehtabi M; Dari MAG; Pour FK; Tabesh GA; Moramezi F; Jafari RM; Barati M; Uddin S; Farzaneh M
BMC Cancer; 2024 Jan; 24(1):4. PubMed ID: 38166752
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA H19 and cancer: A competing endogenous RNA.
Ye Y; Shen A; Liu A
Bull Cancer; 2019 Dec; 106(12):1152-1159. PubMed ID: 31753509
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of Long Noncoding RNA CCAT2 Inhibits Cellular Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Glioma Cells.
Zeng J; Du T; Song Y; Gao Y; Li F; Wu R; Chen Y; Li W; Zhou H; Yang Y; Pei Z
Oncol Res; 2017 Jul; 25(6):913-921. PubMed ID: 27938499
[TBL] [Abstract][Full Text] [Related]
29. H19/let‑7/Lin28 ceRNA network mediates autophagy inhibiting epithelial‑mesenchymal transition in breast cancer.
Xiong H; Shen J; Chen Z; Yang J; Xie B; Jia Y; Jayasinghe U; Wang J; Zhao W; Xie S; Wang L; Zhou J
Int J Oncol; 2020 Mar; 56(3):794-806. PubMed ID: 32124962
[TBL] [Abstract][Full Text] [Related]
30. LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1.
Chang L; Wang J; Zhou F; Wang D; Chen R; Zhang Y; Zhang J
J Neurooncol; 2021 Jan; 151(2):157-171. PubMed ID: 33128099
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
Hong Y; He H; Sui W; Zhang J; Zhang S; Yang D
Int J Oncol; 2018 Mar; 52(3):901-912. PubMed ID: 29344674
[TBL] [Abstract][Full Text] [Related]
32. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis.
Chen MJ; Deng J; Chen C; Hu W; Yuan YC; Xia ZK
Int J Biochem Cell Biol; 2019 Aug; 113():27-36. PubMed ID: 31102664
[TBL] [Abstract][Full Text] [Related]
33.
Rolla M; Jawiarczyk-PrzybyŁowska A; KolaČkov K; Bolanowski M
Anticancer Res; 2021 Feb; 41(2):557-565. PubMed ID: 33517261
[TBL] [Abstract][Full Text] [Related]
34. PANDAR: a pivotal cancer-related long non-coding RNA in human cancers.
Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X
Mol Biosyst; 2017 Oct; 13(11):2195-2201. PubMed ID: 28976505
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
36. LncRNA-ATB: An indispensable cancer-related long noncoding RNA.
Li J; Li Z; Zheng W; Li X; Wang Z; Cui Y; Jiang X
Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28884871
[TBL] [Abstract][Full Text] [Related]
37. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
38. HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer.
Hu XT; Xing W; Zhao RS; Tan Y; Wu XF; Ao LQ; Li Z; Yao MW; Yuan M; Guo W; Li SZ; Yu J; Ao X; Xu X
J Exp Clin Cancer Res; 2020 Dec; 39(1):270. PubMed ID: 33267897
[TBL] [Abstract][Full Text] [Related]
39. The role of long noncoding RNA H19 in gynecological pathologies: Insights into gene regulation and immune modulation (Review).
Xin W; Wang Y; Hua K; Liu S
Int J Mol Med; 2023 Aug; 52(2):. PubMed ID: 37449492
[TBL] [Abstract][Full Text] [Related]
40. lncRNA H19 promotes viability and epithelial-mesenchymal transition of lung adenocarcinoma cells by targeting miR-29b-3p and modifying STAT3.
Liu L; Liu L; Lu S
Int J Oncol; 2019 Mar; 54(3):929-941. PubMed ID: 30747209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
